[
    "This sample is a phase 1 clinical trial for patients with malignant glioma, glioblastoma, or gliosarcoma, testing the drug AP23573, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for individuals diagnosed with schizophrenia who are chronic cannabis users and currently being treated with antipsychotic medication. The study aims to investigate the effects of dronabinol, a drug, on participants' symptoms.",
    "This sample is a phase 1 trial for patients with metastatic melanoma who have received prior Melan-A peptide vaccine and have achieved a detectable immune response. The study aims to evaluate the efficacy of cyclophosphamide and fludarabine phosphate in patients who are not eligible for other protocols due to progressive disease or have reached the maximum number of vaccine injections with stable disease.",
    "This sample is a phase 1 clinical trial testing the drugs mm-121, irinotecan, and cetuximab on patients with colorectal cancer, squamous cell head and neck cancer, non-small cell lung cancer, triple negative breast cancer, and other tumors with EGFR dependence, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial testing the drug combination of bortezomib and ganciclovir in patients with various subtypes of Epstein Barr virus-positive lymphoma who have not responded to previous chemotherapy regimens, and have specific eligibility criteria related to age, disease characteristics, organ function, and prior treatments.",
    "This sample is a phase 1/phase 2 trial for the treatment of osteoarthritis of the knee, testing the drugs fx005, placebo 1 (carrier), and placebo 2 (diluent), with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 clinical trial that aims to test the effectiveness of vorinostat and docetaxel in treating non-small-cell lung carcinoma, prostate cancer, bladder cancer, and urothelial carcinoma that has progressed after chemotherapy or hormone therapy. The eligibility criteria include no prior use of docetaxel, exclusion of patients receiving other investigational agents or prior treatment with HDAC inhibitors, and no significant cardiovascular disease.",
    "This sample is a phase 1/phase 2 trial for patients with advanced lung adenocarcinoma, testing the efficacy of erlotinib hydrochloride and hsp90 inhibitor auy922 in patients who have previously responded to erlotinib or gefitinib or have a documented mutation in the EGFR gene. The study has specific inclusion and exclusion criteria, and patients must meet certain medical conditions and have negative pregnancy tests to be eligible.",
    "This sample is a phase 1 trial for the drug PPI-668 and placebo in patients with chronic hepatitis C, with specific eligibility criteria including age, BMI, health status, and exclusion criteria such as HIV or HBV infection, certain medical conditions, and abnormal laboratory values.",
    "This sample is a phase 1/phase 2 trial for patients with esophageal adenocarcinoma and gastric adenocarcinoma, testing the effectiveness of panitumumab, epirubicin, oxaliplatin, and xeloda as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for patients with lymphoma, specifically diffuse large cell B-cell NHL, who have failed prior systemic chemotherapy. The drug being tested is clofarabine, and the eligibility criteria include specific laboratory values, cardiac function, and understanding of the study. There are also exclusion criteria, such as previous treatment with clofarabine, history of T-cell lymphoma, and certain medical conditions.",
    "This sample is a phase 1/phase 2 clinical trial for patients with brain and central nervous system tumors, extragonadal germ cell tumor, ovarian cancer, and testicular germ cell tumor. The trial involves the use of drugs such as cisplatin, gemcitabine hydrochloride, ifosfamide, and paclitaxel, and has eligibility criteria related to the disease characteristics and patient characteristics.",
    "This sample is a phase 1/phase 2 clinical trial for patients with metastatic hormone receptor-positive HER2-negative breast cancer, testing the drugs fulvestrant, mk-0646, and dasatinib, with eligibility criteria including prior anti-estrogen therapy and easily accessible tumors for biopsy.",
    "This sample is a phase 1 trial for patients with locally advanced pancreatic cancer, testing the effectiveness of capecitabine and gemcitabine hydrochloride as treatment options, with specific eligibility criteria and exclusion criteria.",
    "In this sample, the phase 1 trial is testing the drug azd2171 for advanced cancer patients with hepatic impairment, and the eligibility criteria include written informed consent, advanced solid tumor without standard therapy, WHO performance status 0-2, and bilirubin levels within the target range.",
    "This sample is a phase 1 trial for participants with schizophrenia, testing the effectiveness of paliperidone palmitate in stabilizing psychiatric symptoms, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial that aims to evaluate the effectiveness of various drugs, such as regulatory T-cells and melphalan, in treating diseases like acute leukemia, chronic myelogenous leukemia, myelodysplastic syndrome, non-Hodgkin lymphoma, and chronic lymphocytic leukemia, among others, in patients under 60 years old. The study requires a related donor who is genotypically HLA-haploidentical to the recipient and meets certain health criteria.",
    "This sample is a phase 1/phase 2 trial testing the drugs docetaxel and oxaliplatin on patients with esophageal neoplasms and stomach neoplasms, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with sickle cell disease and pulmonary hypertension, testing the effectiveness of hydroxyurea in reducing tricuspid regurgitant jet velocity.",
    "This sample is a phase 1 trial for patients with type 1 diabetes, testing the efficacy of faster-acting insulin aspart in patients using continuous subcutaneous insulin infusion (CSII) with a MiniMed Paradigm\u00ae pump, with specific inclusion and exclusion criteria.",
    "This study is testing the combination of f16il2 with doxorubicin in patients with advanced solid tumors and breast cancer, with specific eligibility criteria for each phase of the trial.",
    "This sample is a phase 1/phase 2 trial for patients with non-small-cell lung carcinoma, testing the efficacy of a study treatment drug. The eligibility criteria include a histologic or cytologic diagnosis of NSCLC, previous treatment with platinum-based chemotherapy, and a performance status of 0-2 on the ECOG criteria.",
    "This sample is a phase 1/phase 2 trial for patients with end stage renal disease or renal transplant, testing the effectiveness of anti-thymocyte globulin, tol101, steroids, tacrolimus, and mycophenolate mofetil (mmf) as immunosuppressive medications, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 clinical trial for patients with recurrent or metastatic squamous cell carcinoma of the head and neck. The study aims to evaluate the efficacy of the drugs rad001, cetuximab, cisplatin, and carboplatin in treating the disease. The eligibility criteria include specific disease diagnosis, measurable disease, no prior monoclonal antibodies or small molecule tyrosine-kinase inhibitors, and normal organ and marrow function.",
    "This sample is a phase 1/phase 2 clinical trial for patients with stage IV gastric cancer, testing the drug paclitaxel as a potential treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for patients with multiple myeloma and plasma cell neoplasm, testing the effectiveness of bortezomib, melphalan, and pegylated liposomal doxorubicin hydrochloride as treatment options, with specific eligibility criteria and prior concurrent therapy restrictions.",
    "This sample is a phase 1 clinical trial for a vaccine targeting healthy individuals aged 18-50, with specific eligibility criteria including negative HIV and Hepatitis B test results, and exclusion criteria such as autoimmune diseases, asthma, and malignancy.",
    "This sample is a phase 1/phase 2 trial for patients with ER+ and/or PGR+ breast cancer that is refractory to a nonsteroidal aromatase inhibitor, testing the efficacy of xl147 (sar245408), xl765 (sar245409), and letrozole (femara) as potential treatments.",
    "This sample is a phase 1 clinical trial for patients with stage III-IV squamous cell carcinoma of the head and neck, testing the drugs zd6474 (vandetanib) and cisplatin as potential treatments.",
    "This sample is a phase 1/phase 2 trial for urinary incontinence, testing the drugs uish001 and matching placebo, with inclusion criteria being moderate to severe urge, stress, or mixed urinary incontinence, and exclusion criteria including medical history of migraines, neurologic problems, swallowing disorder, stroke, severe depression, heart failure, peripheral edema, moderate to severe asthma, chronic obstructive pulmonary disease (COPD), certain restricted medications, and any other condition that would interfere with the subject's safety.",
    "This sample is a phase 1 clinical trial for patients with leukemia, specifically Ph-positive Chronic Myelogenous Leukemia or Ph+ acute lymphoblastic leukemia, testing the drug dasatinib. The eligibility criteria include age between 1 and 21 years, adequate hepatic and renal function, and written informed consent. Exclusion criteria include prior therapy with dasatinib, uncontrolled medical disorders, and use of certain medications that may cause QTc prolongation.",
    "This sample is a phase 1/phase 2 trial for postmenopausal women with breast cancer and bone diseases, testing the eligibility criteria for adjuvant therapy with aromatase inhibitors and the use of vitamin D as a drug.",
    "This sample is a phase 1/phase 2 trial for lung adenocarcinoma patients who have received treatment with erlotinib, and it will test the efficacy of erlotinib with cetuximab as a potential treatment option.",
    "This sample is a phase 1 trial testing the drugs sunitinib malate and rapamycin for the treatment of tumors, with specific eligibility criteria including histologically confirmed malignancy, measurable disease, ECOG performance status of 0-1, and normal cardiac ejection fraction.",
    "This sample is a phase 1 clinical trial for patients with refractory solid tumors and pancreatic adenocarcinoma, testing the combination of gemcitabine and dasatinib as a potential treatment option. The eligibility criteria include specific disease requirements, prior treatment restrictions, and general patient characteristics.",
    "This sample is a phase 1/phase 2 trial for type 2 diabetes, testing the drugs xoma 052 and placebo, with eligibility criteria including specific blood glucose levels, HbA1c range, stable disease, age range, weight range, BMI range, negative pregnancy test for females, and restrictions on certain medications.",
    "This sample is a phase 1 clinical trial for patients with metastatic or unresectable solid tumor malignancy, testing the drug sjg-136, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with recurrent prostate cancer, testing the effectiveness of various drugs such as leuprolide acetate and temsirolimus, with specific eligibility criteria including PSA levels and no evidence of metastasis.",
    "This sample is a phase 1 trial for patients with operable breast cancer, testing the effectiveness of paclitaxel, gemcitabine, and lapatinib as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for adult patients with acute myeloid leukemia (AML) who are either newly diagnosed and not eligible for intensive induction therapy or have relapsed/refractory AML and are not eligible for stem cell transplantation. The study will test the drug cytarabine as a low-intensity therapy option for these patients.",
    "This sample is a phase 1 clinical trial for patients with advanced solid tumors, testing the drugs tas-102 and trifluridine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for diabetes, testing the drug metformin, with inclusion criteria including individuals aged 35-55 with no known history of diabetes, and exclusion criteria including pregnant women and subjects with major illnesses such as cancer or hepatic diseases.",
    "This sample is a phase 1 trial for a hepatitis C vaccine, testing the safety and eligibility criteria for healthy adults, with the inclusion of various medical tests and exclusion criteria, such as excluding individuals with diabetes, cancer, liver disease, and high-risk behaviors for HCV infection.",
    "This sample is a phase I trial for patients diagnosed with relapsing remitting multiple sclerosis, testing the effectiveness of mycophenolate mofetil (cellcept) and human interferon beta 1a (rebif) as potential treatments, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with metastatic colorectal cancer, testing the drugs panitumumab and conatumumab, with eligibility criteria including documented disease progression and specific hematologic, renal, hepatic, and metabolic function limits.",
    "This sample is a phase 1/phase 2 trial for patients with renal cell carcinoma (RCC) that tests the effectiveness of ril-21 alone or in combination with sorafenib as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with advanced solid tumors, testing the drug BIBF 1120, with specific inclusion and exclusion criteria.",
    "This sample is a phase I clinical trial for patients with traumatic brain injury and epilepsy, testing the effectiveness of topiramate and phenytoin as potential treatments, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for a vaccine enhancement patch targeting healthy adults, with specific inclusion and exclusion criteria, and various restrictions on prior vaccinations, allergies, medical conditions, and other factors.",
    "This sample is a phase 1 trial for patients diagnosed with colon cancer, where the drug being tested is resveratrol, and the eligibility criteria include having a plan for surgical resection at UCIMC within 2-4 weeks of enrollment.",
    "This sample is a phase 1 trial for patients with metastatic colorectal cancer, testing the drugs osi-906 and everolimus, with eligibility criteria including specific disease progression and tolerability to previous treatments, as well as various health and laboratory requirements.",
    "This sample is a phase 1/phase 2 trial for patients with locally advanced and non-metastatic rectal adenocarcinoma, testing the drugs S-1 and oxaliplatin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drug levonorgestrel for contraception, with specific inclusion and exclusion criteria, and various medical conditions and medications that would disqualify participants from the study.",
    "This sample is a phase 1 trial testing the drug bms-690514 on patients with solid tumors, with specific inclusion and exclusion criteria, such as prior treatment restrictions and certain medical conditions.",
    "This sample is a phase 1 trial for patients with acute coronary syndromes, testing the use of clopidogrel and prasugrel as part of a treatment regimen, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial testing the combination of oratecan and capecitabine in patients with advanced solid tumors who have not responded to conventional anticancer therapy, and it includes specific eligibility criteria for enrollment.",
    "This sample is a phase 1 trial for patients with advanced cancer, testing the drugs ly2603618, pemetrexed, and gemcitabine, with eligibility criteria including a histological or cytological diagnosis of cancer, no life-prolonging therapy available, and adequate hematologic, hepatic, and renal function.",
    "This sample is a phase 1 trial for endometriosis, testing the drug thalidomide, with inclusion criteria including confirmed endometriosis, chronic pelvic pain, and failure or intolerance of standard treatments. Exclusion criteria include pregnancy, use of other angiogenesis inhibitors, and certain medication use.",
    "This sample is a phase 1 clinical trial for patients with metastatic or unresectable malignant solid tumors, testing the effectiveness of irinotecan hydrochloride and thalidomide as treatment options, with specific eligibility criteria including stable neurologic status, normal blood counts, and absence of certain medical conditions.",
    "This sample is a phase 1 clinical trial for the drug gft505 in patients with type 2 diabetes, with specific inclusion and exclusion criteria, and different phases and disease codes for each phase.",
    "This sample is a phase 1 trial for patients with advanced or recurrent endometrial cancer, testing the drugs topotecan and rad001, with eligibility criteria including refractory to standard therapy, age \u2265 18 years, and adequate bone marrow and liver function.",
    "This sample is a phase 1 trial for a drug called gw642444h, along with a placebo and another drug called gw642444m, in patients with chronic obstructive pulmonary disease. The eligibility criteria include having a history of stable mild to moderate asthma, being a non-smoker, and currently taking a specific dose of inhaled fluticasone propionate.",
    "This sample is a phase 1 clinical trial for patients with an unspecified adult solid tumor, testing the drug talotrexin ammonium. The eligibility criteria include having a diagnosis of malignant solid tumor, no known curative or survival-prolonging palliative therapy, and meeting certain patient characteristics such as age, performance status, and hematopoietic levels.",
    "This sample is a phase 1/phase 2 trial for Hodgkin's disease, testing the drugs prednisone, vinblastine, doxorubicin, and gemcitabine, with specific eligibility criteria for patients aged 60 to 75 years.",
    "This sample is a phase 1/phase 2 trial for high-risk hematologic malignancies, including acute leukemia, myelodysplastic syndromes, Hodgkin's lymphoma, non-Hodgkin's lymphoma, myeloma, and chronic myelogenous leukemia, using fludarabine, thiotepa, and melphalan as drugs, with specific eligibility criteria and donor selection requirements.",
    "This sample is a phase 1 trial for depression, testing the drugs azd6765, ketamine, and placebo, with inclusion criteria including a clinical diagnosis of major depressive disorder and exclusion criteria including a history of schizophrenia or bipolar disorder.",
    "This sample is a phase 1 trial for patients with myelodysplastic syndrome, testing the drug clofarabine, and includes eligibility criteria such as specific IPSS scores, age requirements, and adequate renal and hepatic functions.",
    "This sample is a phase 1 clinical trial for asthma, testing the drugs amg 157 matching placebo and amg 157, with inclusion criteria including mild atopic asthma, specific BMI range, and normal physical examination, and exclusion criteria including certain medical conditions and recent infections.",
    "This sample is a phase 1/phase 2 clinical trial for patients diagnosed with non-small cell lung cancer, testing the drugs pemetrexed and cisplatin in different phases, with specific eligibility criteria including age, disease diagnosis, and required blood, liver, lung, and kidney function.",
    "This sample is a phase 1/phase 2 trial for the treatment of psoriasis using the drug Humira, along with 3 B vitamins, and the eligibility criteria include having moderate to severe plaque psoriasis, being 18 years or older, and not having certain medical conditions or taking certain medications.",
    "This sample is a phase 1 clinical trial for atopic dermatitis, testing the efficacy of placebo and dupilumab drugs in patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This study is testing the effectiveness of d-methadone and placebo in treating chronic pain in patients with various types of cancer, with specific inclusion and exclusion criteria for each phase of the trial.",
    "This sample is a phase 1 clinical trial testing the drug cnto 136 on patients with lupus erythematosus, both cutaneous and systemic, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial testing the drug sirolimus on kidney transplant recipients, specifically those who have lost their first transplant due to technical reasons or recurrent disease. The study includes eligibility criteria such as age over 18, negative pregnancy test for females of childbearing age, and informed consent.",
    "This sample is a phase 1/phase 2 trial for patients with multiple myeloma, testing the drugs doxil, melphalan, and bortezomib, with eligibility criteria including previous diagnosis of multiple myeloma, progressive disease, and specific patient characteristics.",
    "This sample is a phase 1 clinical trial testing the drug inno-105 on patients with tumors, who are not eligible for other effective therapies, and meet certain inclusion criteria, while excluding those who have received previous treatment with inno-105 or have certain medical conditions.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small cell lung cancer, testing the drug abi-007, with eligibility criteria including advanced stage IV NSCLC, no prior chemotherapies for metastatic disease, and specific baseline laboratory values.",
    "This sample is a phase 1/phase 2 trial that focuses on patients with various types of germ cell tumors, including brain and central nervous system tumors, extragonadal germ cell tumor, ovarian cancer, teratoma, and testicular germ cell tumor. The study aims to evaluate the effectiveness of carboplatin, ifosfamide, and paclitaxel in treating advanced disease that is resistant to cisplatin-based chemotherapy. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy requirements.",
    "This sample is a phase 1 trial for chronic obstructive pulmonary disease (COPD) patients, testing drugs pf-03715455 and ph-797804, along with their respective placebos, to evaluate their effectiveness in improving lung function and airway responsiveness. The inclusion and exclusion criteria specify the eligibility requirements for the study participants.",
    "This sample is a phase 1 trial for patients with type 2 diabetes mellitus, testing the drug LY2608204, and includes eligibility criteria such as specific blood glucose levels, age range, BMI range, and exclusion criteria such as history of certain disorders, use of certain medications, and allergies to LY2608204 or related compounds.",
    "This sample is a phase 1 trial for individuals with type 2 diabetes, testing the drugs placebo and LY2409021, with inclusion criteria including specific diabetes control methods and certain health measurements, and exclusion criteria including insulin use, certain medications, and various medical conditions.",
    "This sample is a phase 1/phase 2 clinical trial for patients with unresectable hepatocellular carcinoma (HCC), testing the drug sorafenib. The eligibility criteria include having measurable disease, adequate blood test results, suitable hepatic arterial anatomy, and a life expectancy of at least 3 months without active treatment. Exclusion criteria include previous radiation therapy to the liver, liver failure, abnormal liver function tests, and previous hepatic artery directed therapy.",
    "This sample is a phase 1 trial for healthy subjects, testing the effects of olanzapine and zyprexa tablets on individuals aged 18 and older, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for healthy volunteers, testing the effects of glycopyrrolate on lung function, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drugs droxidopa, atenolol, and placebos for the treatment of postural orthostatic tachycardia syndrome and orthostatic intolerance, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for liver cancer, hepatocellular carcinoma, and cholangiocarcinoma, testing the drug bevacizumab, with eligibility criteria including proof of primary liver cancer, tumor size restrictions, and specific laboratory values.",
    "This sample is a phase 1 trial for patients with type 2 diabetes mellitus and renal impairment, testing the drug LX4211 and its placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with type 2 diabetes mellitus, testing the drug pf-04991532 and a placebo, with eligibility criteria including stable treatment with a single oral anti-diabetic drug and specific HbA1c levels.",
    "This sample is a clinical trial study that aims to evaluate the efficacy of the drug gamma-secretase/notch signalling pathway inhibitor ro4929097 in patients with various types of cancer, including estrogen receptor-negative breast cancer, extensive stage small cell lung cancer, and recurrent melanoma, who have newly diagnosed metastatic disease to the brain. The study has specific inclusion and exclusion criteria, and patients must meet certain eligibility requirements to participate.",
    "This sample is a phase 1 trial for the treatment of hepatitis C, testing the drugs gs-9669 tablets and placebo, with specific eligibility criteria including age, HCV infection duration, genotype, creatinine clearance, QTcF interval, BMI, and exclusion criteria such as drug use, liver function, ANC count, co-infection, hepatocellular carcinoma, cardiac disease, gastrointestinal disorders, and major medical disorders.",
    "This sample is a phase 1 trial for the drug ly2409021, placebo, and glucagon in patients with type 1 diabetes mellitus, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for rheumatoid arthritis, testing the efficacy of abatacept or placebo (both as iv & sc solution) in patients who meet ARA criteria for diagnosis of RA with active disease and have been diagnosed for at least 1 year, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with hematologic malignancies, testing the drugs bortezomib (velcade), tacrolimus, and methotrexate, with eligibility criteria including high-risk patients after myeloablative transplantation, mismatched donors, and specific age and health requirements.",
    "This sample is a phase 1 clinical trial testing the drug ABT-888 in combination with whole brain radiation therapy (WBRT) for patients with brain metastases from non-CNS primary solid malignancies, and it includes eligibility criteria for enrollment in the study.",
    "This sample is a phase 1 clinical trial for patients with relapsed or progressive multiple myeloma, testing the efficacy of the drugs jnj-2641585, velcade, and dexamethasone, with specific eligibility criteria and exclusion criteria related to cardiac health and prior treatments.",
    "This sample is a phase 1 trial for type 2 diabetes mellitus, testing the drugs oxyntomodulin and liraglutide, along with placebos, and includes eligibility criteria such as BMI, HbA1C levels, and exclusion criteria related to medical history and lifestyle factors.",
    "This sample is a phase 1 trial for patients with prostate cancer, testing the drugs zd4054 (zibotentan), docetaxel, and placebo, with eligibility criteria including evidence of metastatic disease, progressive disease, and a World Health Organization performance status of 0 to 2.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic or recurrent gastric cancer, testing the drugs taxol and campt, topotesin, with eligibility criteria including prior treatment for advanced disease, measurable lesions, specific hematologic values, and normal ECG.",
    "This sample is a phase 1 trial for the drug azilsartan medoxomil (tak-491) in pediatric and adult participants with hypertension, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 trial for esophageal cancer, testing the drugs cisplatin, gefitinib, and irinotecan hydrochloride, with eligibility criteria including surgically resectable tumor, specific lymph node criteria, and various patient characteristics.",
    "This sample is a phase 1 trial for patients with type 1 diabetes, testing the effectiveness of insulin degludec and insulin glargine in controlling blood sugar levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for asthma, testing the drugs qax576 and placebo, with inclusion criteria including a history of asthma attacks and taking inhaled corticosteroids, and exclusion criteria including women of child-bearing potential and previous use of monoclonal antibodies.",
    "This sample is a phase 1 trial for lenalidomide in patients with adult T-cell leukemia-lymphoma or peripheral T-cell lymphoma, with specific inclusion and exclusion criteria, and various medical history and laboratory test requirements.",
    "This sample is a phase 1/phase 2 trial testing the drugs everolimus and gefitinib for patients with glioblastoma multiforme or castrate metastatic prostate cancer, who have progressive disease despite standard therapy, and meet specific eligibility criteria.",
    "This sample is a phase 1/phase 2 trial for rheumatoid arthritis, testing the drugs belatacept and abatacept, with specific inclusion and exclusion criteria for participants.",
    "This phase 1 trial aims to evaluate the safety and efficacy of embeda (morphine sulfate/naltrexone hydrochloride) in recreational opioid users with conditions such as narcotic abuse, opioid-related disorders, analgesia, and chronic pain. The study will include healthy male and female subjects aged 18 to 55 who have experience with intranasal drug administration. Exclusion criteria include substance and alcohol dependence, contraindications to opioids, and significant medical conditions.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic melanoma, testing the combination of dasatinib and dacarbazine (dtic) as a potential treatment, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for the treatment of primary open-angle glaucoma and ocular hypertension, using lx7101 (0.125%), lx7101 (0.25%), and lx7101 vehicle as drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for the treatment of pulmonary arterial hypertension, testing the drugs sitaxentan, tadalafil, and sildenafil, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 1/phase 2 trial for pancreatic adenocarcinoma, testing the drugs pimasertib, gemcitabine, and placebo, with eligibility criteria including confirmed metastatic adenocarcinoma of the pancreas and availability of tumor sample, age \u2265 18 years, and negative pregnancy test for women of childbearing potential.",
    "This sample is a phase 1 clinical trial testing the drugs o6-benzylguanine, carmustine, and temozolomide for the treatment of brain and central nervous system tumors, lymphoma, and unspecified adult solid tumors, with specific eligibility criteria including age, performance status, hematopoietic, hepatic, renal, cardiovascular, and pulmonary conditions, as well as prior concurrent therapies.",
    "This sample is a phase 1 trial for patients with hormone refractory prostate cancer, testing the drug mdv3100, and includes eligibility criteria such as confirmed adenocarcinoma of the prostate and progressive disease after medical or surgical castration.",
    "This sample is a phase 1 clinical trial for patients with prostate adenocarcinoma, testing the drug cabozantinib, and includes eligibility criteria such as confirmed bone metastases and castration-resistant disease.",
    "This sample is a phase 1 trial for patients with glioblastoma multiforme (GBM) that have progressed following primary therapy, and the study is testing the drugs fludarabine and cyclophosphamide as potential treatments. The eligibility criteria include age range, histopathologic diagnosis of GBM, CMV pp65 or IE1 positive tumor, specific health parameters, and performance status.",
    "This sample is a phase 1 trial for patients with pancreatic neoplasms, testing the drugs ku-0059436 (azd2281)(parp inhibitor) and gemcitabine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for melanoma, testing the drugs intetumumab, dacarbazine, and placebo, with specific inclusion and exclusion criteria for patients.",
    "This sample is a phase 1 trial for patients with kidney cancer and unspecified adult solid tumors, testing the drugs rad001 (everolimus) and ptk787 (vatalanib), with eligibility criteria including specific disease characteristics and patient characteristics."
]
